Abstract
Background A 51-year-old male presented with a penile deformity without obvious etiology. Physical examination revealed hard plaques in the dorsal and ventral penis.
Investigations Physical examination, penile ultrasound.
Diagnosis Peyronie's disease.
Management Oral pentoxifylline.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schwarzer U et al. (2001) The prevalence of Peyronie's disease: results of a large survey. BJU Int 88: 727–730
Mulhall JP et al. (2004) Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol 171: 2350–2353
Gholami SS et al. (2002) Peyronie's disease: a review. J Urol 169: 1234–1241
Williams JL and Thomas GG (1970) The natural history of Peyronie's disease. J Urol 103: 75–76
Gelbard MK et al. (1990) The natural history of Peyronie's disease. J Urol 144: 1376–1379
Zargooshi J (2004) Trauma as the cause of Peyronie's disease: penile fracture as a model of trauma. J Urol 172: 186–188
Levine LA and Greenfield JM (2003) Establishing a standardized evaluation of the man with Peyronie's disease. Int J Impot Res 15 (Suppl): S103–S112
Hauck EW et al. (2003) Diagnostic value of magnetic resonance imaging in Peyronie's disease: a comparison both with palpation and ultrasound in the evaluation of plaque formation. Eur Urol 43: 293–300
Chiao TB and Lee AJ (2005) Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis. Ann Pharmacother 39: 516–522
Delanian S et al. (2005) Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 22: 1–10
Haddad P et al. (2005) Pentoxifylline and vitamin E combination for superficial radiation-induced fibrosis: a phase II clinical trial. Radiother Oncol 77: 324–326
Hille A et al. (2005) Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 181: 606–614
Adams LA et al. (2004) A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am J Gastroenterol 99: 2365–2368
Georges C et al. (2004) Case report: resolution of symptomatic epidural fibrosis following treatment with combined pentoxifylline–tocopherol. Br J Radiol 77: 885–887
Delanian S and Lefaix JL (2002) Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate. Br J Radiol 75: 467–469
Valente EG et al. (2003) L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide 9: 229–244
Videla S et al. Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis. J Pharmacol Exp Ther, in press
Gumus B et al. (2004) Histopathological effects of sildenafil citrate on rat corpus cavernosum. Acta Histochem 106: 37–45
Schwartz EJ et al. (2004) Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 171: 771–774
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Brant, W., Dean, R. & Lue, T. Treatment of Peyronie's disease with oral pentoxifylline. Nat Rev Urol 3, 111–115 (2006). https://doi.org/10.1038/ncpuro0409
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0409
This article is cited by
-
Patients with Peyronie’s disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series
Journal of Medical Case Reports (2022)
-
Aktuelle Therapie der Induratio penis plastica (IPP)
Der Urologe (2018)
-
Repurposing Pentoxifylline for the Treatment of Fibrosis: An Overview
Advances in Therapy (2017)